- Investing Ideas
- /
- Chinese Healthcare Undervalued Stocks Based On Cash Flows
Chinese Healthcare Undervalued Stocks Based On Cash Flows
Results
4
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
4 companies
BMC Medical
Market Cap: CN¥6.1b
Researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China.
301367
CN¥68.95
7D
9.6%
1Y
32.1%
Zhende Medical
Market Cap: CN¥5.6b
Engages in the research and development, production, and sale of medical care and protective equipment in China.
603301
CN¥20.87
7D
4.9%
1Y
10.6%
Shenzhen New Industries Biomedical Engineering
Market Cap: CN¥40.3b
Engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally.
300832
CN¥51.28
7D
-5.2%
1Y
-19.2%
SWS Hemodialysis Care
Market Cap: CN¥3.7b
Provides integrated blood purification solutions for renal failure and critically ill patients worldwide.
688410
CN¥11.49
7D
10.4%
1Y
-23.3%